NovaBridge Biosciences American Depositary Shares
NBP
42 hedge funds and large institutions have $112M invested in NovaBridge Biosciences American Depositary Shares in 2025 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 11 closing their positions.
394% more capital invested
Capital invested by funds: $22.7M → $112M (+$89.6M)
91% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 11
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
33% more call options, than puts
Call options by funds: $292K | Put options by funds: $220K
31% more funds holding
Funds holding: 32 → 42 (+10)
14.31% more ownership
Funds ownership: 11.51% → 25.82% (+14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$27.1M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$11.3M |
| 3 |
Morgan Stanley
New York
|
+$7.38M |
| 4 |
ACM
Ariose Capital Management
Central, Hong Kong,
Hong Kong
|
+$5.46M |
| 5 |
EAM
Exome Asset Management
New York
|
+$4.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
-$1.4M |
| 2 |
Two Sigma Advisers
New York
|
-$507K |
| 3 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$315K |
| 4 |
Two Sigma Investments
New York
|
-$274K |
| 5 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$181K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CIAM
51
Caitong International Asset Management
Hong Kong
| – | -$3.02K | -1,248 | Closed |
|
52
Raymond James Financial
St Petersburg,
Florida
| – | -$2.42K | -1,000 | Closed |
|
53
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$2 | -1 | Closed |
|
NBP Hedge Fund Activity: Q3 2025 in Review
42 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q3 2025, worth a combined $112M — up 394% from $22.7M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new NBP positions and 11 closed out — a net gain of 10 holders — while 10 added to existing stakes and 6 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $27.1M. The largest seller was SG Americas Securities, cutting an estimated $1.4M.
- 42 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q3 2025, up from 32 in Q2 2025.
- Funds reported $112M of NovaBridge Biosciences American Depositary Shares stock for Q3 2025, up 394% quarter-over-quarter.
- 21 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q3 2025 and 11 closed out, a net change of +10 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q3 2025 was Janus Henderson Group, an estimated $27.1M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q3 2025 was SG Americas Securities, an estimated $1.4M sold.
Based on aggregated 13F filings for Q3 2025.